HEADER TRANSFERASE 17-AUG-18 6HD6 TITLE ABL1 IN COMPLEX WITH COMPOUND6 AND IMATINIB (STI-571) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 6 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: ABL1, ABL; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: SF9 KEYWDS PHOSPHOTRANSFERASE, INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.W.COWAN-JACOB REVDAT 3 15-MAY-24 6HD6 1 HETSYN REVDAT 2 10-OCT-18 6HD6 1 JRNL REVDAT 1 12-SEP-18 6HD6 0 JRNL AUTH J.SCHOEPFER,W.JAHNKE,G.BERELLINI,S.BUONAMICI,S.COTESTA, JRNL AUTH 2 S.W.COWAN-JACOB,S.DODD,P.DRUECKES,D.FABBRO,T.GABRIEL, JRNL AUTH 3 J.M.GROELL,R.M.GROTZFELD,A.Q.HASSAN,C.HENRY,V.IYER,D.JONES, JRNL AUTH 4 F.LOMBARDO,A.LOO,P.W.MANLEY,X.PELLE,G.RUMMEL,B.SALEM, JRNL AUTH 5 M.WARMUTH,A.A.WYLIE,T.ZOLLER,A.L.MARZINZIK,P.FURET JRNL TITL DISCOVERY OF ASCIMINIB (ABL001), AN ALLOSTERIC INHIBITOR OF JRNL TITL 2 THE TYROSINE KINASE ACTIVITY OF BCR-ABL1. JRNL REF J. MED. CHEM. V. 61 8120 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30137981 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01040 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.3.0040 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 26528 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1397 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1990 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.66 REMARK 3 BIN R VALUE (WORKING SET) : 0.2050 REMARK 3 BIN FREE R VALUE SET COUNT : NULL REMARK 3 BIN FREE R VALUE : 0.3340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4612 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 102 REMARK 3 SOLVENT ATOMS : 385 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.78000 REMARK 3 B22 (A**2) : 0.48000 REMARK 3 B33 (A**2) : 0.63000 REMARK 3 B12 (A**2) : -0.01000 REMARK 3 B13 (A**2) : 0.21000 REMARK 3 B23 (A**2) : -0.69000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.386 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.250 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.171 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HD6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1200011517. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97810 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27927 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 37.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 1.990 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.99 REMARK 200 R MERGE FOR SHELL (I) : 0.24400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21.4 % PEG 4000, 0.2 M MGCL2, 0.1 M REMARK 280 MES PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 242 REMARK 465 ASP A 295 REMARK 465 THR A 296 REMARK 465 GLY A 530 REMARK 465 LYS A 531 REMARK 465 ARG A 532 REMARK 465 GLY A 533 REMARK 465 THR A 534 REMARK 465 GLY B 242 REMARK 465 ALA B 243 REMARK 465 GLU B 294 REMARK 465 ASP B 295 REMARK 465 THR B 296 REMARK 465 GLY B 530 REMARK 465 LYS B 531 REMARK 465 ARG B 532 REMARK 465 GLY B 533 REMARK 465 THR B 534 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 821 O HOH A 856 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 264 -145.47 -105.15 REMARK 500 ARG A 381 -25.73 91.97 REMARK 500 ASP A 382 59.13 -143.32 REMARK 500 ARG A 405 53.21 -113.78 REMARK 500 LEU A 406 -43.45 -140.86 REMARK 500 LYS B 264 -134.06 -113.39 REMARK 500 LYS B 266 130.68 -20.84 REMARK 500 GLU B 298 32.66 -98.12 REMARK 500 HIS B 314 143.23 -174.41 REMARK 500 ARG B 381 -17.40 85.37 REMARK 500 ASP B 382 48.41 -148.51 REMARK 500 ALA B 384 147.93 -173.53 REMARK 500 ASN B 393 31.20 70.59 REMARK 500 ALA B 416 -1.99 74.02 REMARK 500 ASP B 463 108.99 -37.53 REMARK 500 ASP B 474 23.22 81.76 REMARK 500 PRO B 484 138.70 -39.74 REMARK 500 PHE B 516 45.11 -105.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FYH A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue STI A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue STI B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6HD4 RELATED DB: PDB DBREF 6HD6 A 248 534 UNP P00520 ABL1_MOUSE 229 515 DBREF 6HD6 B 248 534 UNP P00520 ABL1_MOUSE 229 515 SEQADV 6HD6 GLY A 242 UNP P00520 EXPRESSION TAG SEQADV 6HD6 ALA A 243 UNP P00520 EXPRESSION TAG SEQADV 6HD6 MET A 244 UNP P00520 EXPRESSION TAG SEQADV 6HD6 ASP A 245 UNP P00520 EXPRESSION TAG SEQADV 6HD6 PRO A 246 UNP P00520 EXPRESSION TAG SEQADV 6HD6 SER A 247 UNP P00520 EXPRESSION TAG SEQADV 6HD6 GLY B 242 UNP P00520 EXPRESSION TAG SEQADV 6HD6 ALA B 243 UNP P00520 EXPRESSION TAG SEQADV 6HD6 MET B 244 UNP P00520 EXPRESSION TAG SEQADV 6HD6 ASP B 245 UNP P00520 EXPRESSION TAG SEQADV 6HD6 PRO B 246 UNP P00520 EXPRESSION TAG SEQADV 6HD6 SER B 247 UNP P00520 EXPRESSION TAG SEQRES 1 A 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 A 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 A 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 A 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 A 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 A 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 A 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 A 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 A 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 A 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 A 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 A 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 A 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 A 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 A 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 A 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 A 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 A 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 A 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 A 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 A 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 A 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 A 293 GLU LEU GLY LYS ARG GLY THR SEQRES 1 B 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 B 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 B 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 B 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 B 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 B 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 B 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 B 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 B 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 B 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 B 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 B 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 B 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 B 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 B 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 B 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 B 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 B 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 B 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 B 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 B 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 B 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 B 293 GLU LEU GLY LYS ARG GLY THR HET CL A 601 1 HET FYH A 602 54 HET STI A 603 37 HET STI B 601 37 HETNAM CL CHLORIDE ION HETNAM FYH 3-(MORPHOLIN-4-YLMETHYL)-~{N}-[4-(TRIFLUOROMETHYLOXY) HETNAM 2 FYH PHENYL]BENZAMIDE HETNAM STI 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4- HETNAM 2 STI PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE HETSYN STI STI-571; IMATINIB FORMUL 3 CL CL 1- FORMUL 4 FYH C19 H19 F3 N2 O3 FORMUL 5 STI 2(C29 H31 N7 O) FORMUL 7 HOH *385(H2 O) HELIX 1 AA1 GLU A 257 THR A 259 5 3 HELIX 2 AA2 GLY A 268 GLN A 271 5 4 HELIX 3 AA3 GLU A 298 LYS A 310 1 13 HELIX 4 AA4 LEU A 342 CYS A 349 1 8 HELIX 5 AA5 SER A 355 LYS A 376 1 22 HELIX 6 AA6 ALA A 384 ARG A 386 5 3 HELIX 7 AA7 GLU A 392 HIS A 394 5 3 HELIX 8 AA8 PRO A 421 THR A 425 5 5 HELIX 9 AA9 ALA A 426 ASN A 433 1 8 HELIX 10 AB1 SER A 436 THR A 453 1 18 HELIX 11 AB2 ASP A 463 SER A 465 5 3 HELIX 12 AB3 GLN A 466 LYS A 473 1 8 HELIX 13 AB4 PRO A 484 TRP A 495 1 12 HELIX 14 AB5 ASN A 498 ARG A 502 5 5 HELIX 15 AB6 SER A 504 PHE A 516 1 13 HELIX 16 AB7 SER A 520 LEU A 529 1 10 HELIX 17 AB8 GLU B 257 THR B 259 5 3 HELIX 18 AB9 GLY B 268 GLN B 271 5 4 HELIX 19 AC1 GLU B 298 LYS B 310 1 13 HELIX 20 AC2 ASN B 341 CYS B 349 1 9 HELIX 21 AC3 SER B 355 LYS B 376 1 22 HELIX 22 AC4 ALA B 384 ARG B 386 5 3 HELIX 23 AC5 GLU B 392 HIS B 394 5 3 HELIX 24 AC6 GLY B 402 MET B 407 1 6 HELIX 25 AC7 PRO B 421 THR B 425 5 5 HELIX 26 AC8 ALA B 426 ASN B 433 1 8 HELIX 27 AC9 SER B 436 THR B 453 1 18 HELIX 28 AD1 GLN B 466 LYS B 473 1 8 HELIX 29 AD2 PRO B 484 TRP B 495 1 12 HELIX 30 AD3 ASN B 498 ARG B 502 5 5 HELIX 31 AD4 SER B 504 THR B 514 1 11 HELIX 32 AD5 SER B 520 LYS B 527 1 8 SHEET 1 AA1 5 ILE A 261 LYS A 266 0 SHEET 2 AA1 5 VAL A 275 TRP A 280 -1 O GLU A 277 N HIS A 265 SHEET 3 AA1 5 LEU A 285 THR A 291 -1 O VAL A 289 N TYR A 276 SHEET 4 AA1 5 TYR A 331 GLU A 335 -1 O ILE A 332 N LYS A 290 SHEET 5 AA1 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333 SHEET 1 AA2 3 GLY A 340 ASN A 341 0 SHEET 2 AA2 3 CYS A 388 VAL A 390 -1 O VAL A 390 N GLY A 340 SHEET 3 AA2 3 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389 SHEET 1 AA3 2 THR A 413 HIS A 415 0 SHEET 2 AA3 2 ALA A 418 PHE A 420 -1 O ALA A 418 N HIS A 415 SHEET 1 AA4 5 ILE B 261 LYS B 266 0 SHEET 2 AA4 5 VAL B 275 TRP B 280 -1 O VAL B 279 N THR B 262 SHEET 3 AA4 5 LEU B 285 THR B 291 -1 O LEU B 285 N TRP B 280 SHEET 4 AA4 5 TYR B 331 GLU B 335 -1 O ILE B 332 N LYS B 290 SHEET 5 AA4 5 LEU B 320 CYS B 324 -1 N GLY B 322 O ILE B 333 SHEET 1 AA5 2 CYS B 388 VAL B 390 0 SHEET 2 AA5 2 VAL B 396 VAL B 398 -1 O LYS B 397 N LEU B 389 SHEET 1 AA6 2 THR B 413 HIS B 415 0 SHEET 2 AA6 2 ALA B 418 PHE B 420 -1 O ALA B 418 N HIS B 415 CISPEP 1 PRO A 328 PRO A 329 0 6.66 CISPEP 2 PRO B 328 PRO B 329 0 -6.87 SITE 1 AC1 3 ILE A 379 HOH A 886 HOH A 935 SITE 1 AC2 19 LEU A 359 LEU A 360 ALA A 363 LEU A 448 SITE 2 AC2 19 ILE A 451 ALA A 452 THR A 453 TYR A 454 SITE 3 AC2 19 MET A 456 GLU A 481 CYS A 483 PRO A 484 SITE 4 AC2 19 VAL A 487 PHE A 512 ILE A 521 VAL A 525 SITE 5 AC2 19 LEU A 529 HOH A 776 HOH A 852 SITE 1 AC3 17 VAL A 275 ALA A 288 LYS A 290 GLU A 305 SITE 2 AC3 17 MET A 309 VAL A 318 ILE A 332 THR A 334 SITE 3 AC3 17 PHE A 336 MET A 337 ILE A 379 HIS A 380 SITE 4 AC3 17 LEU A 389 ALA A 399 ASP A 400 PHE A 401 SITE 5 AC3 17 HOH A 846 SITE 1 AC4 15 LEU B 267 VAL B 275 ALA B 288 LYS B 290 SITE 2 AC4 15 GLU B 305 MET B 309 ILE B 312 VAL B 318 SITE 3 AC4 15 THR B 334 MET B 337 ILE B 379 HIS B 380 SITE 4 AC4 15 ASP B 400 PHE B 401 HOH B 749 CRYST1 42.080 65.201 66.347 73.30 79.82 84.54 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023764 -0.002270 -0.003786 0.00000 SCALE2 0.000000 0.015407 -0.004426 0.00000 SCALE3 0.000000 0.000000 0.015932 0.00000